COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

Neurology. 2020 Aug 4;95(5):221-223. doi: 10.1212/WNL.0000000000009700. Epub 2020 May 1.

Affiliations

¹ From the Department of Neurology (M.D., V.G., J.K., S.B., M.S., P.W., J.H., D.L.), Department of Ophthalmology (M.D., C.G.), Department of Medicine (G.M.) and Department of Radiology (G.S., A.J.T.), Weill Cornell Medical College, New York. [email protected].
² From the Department of Neurology (M.D., V.G., J.K., S.B., M.S., P.W., J.H., D.L.), Department of Ophthalmology (M.D., C.G.), Department of Medicine (G.M.) and Department of Radiology (G.S., A.J.T.), Weill Cornell Medical College, New York.

PMID: 32358218
DOI: 10.1212/WNL.0000000000009700

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Aged
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy
Coronavirus Infections / physiopathology
Diplopia / diagnostic imaging
Diplopia / etiology*
Diplopia / physiopathology
Enzyme Inhibitors / therapeutic use
Female
Humans
Hydroxychloroquine / therapeutic use
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Magnetic Resonance Imaging
Male
Miller Fisher Syndrome / diagnostic imaging
Miller Fisher Syndrome / etiology*
Miller Fisher Syndrome / physiopathology
Miller Fisher Syndrome / therapy
Oculomotor Nerve / diagnostic imaging
Ophthalmoplegia / diagnostic imaging
Ophthalmoplegia / etiology*
Ophthalmoplegia / physiopathology
Optic Nerve / diagnostic imaging
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy
Pneumonia, Viral / physiopathology
SARS-CoV-2

Substances

Enzyme Inhibitors
Immunoglobulins, Intravenous
Immunologic Factors
Hydroxychloroquine